» Articles » PMID: 26867589

Regulation of the Tumour Suppressor PDCD4 by MiR-499 and MiR-21 in Oropharyngeal Cancers

Overview
Journal BMC Cancer
Publisher Biomed Central
Specialty Oncology
Date 2016 Feb 13
PMID 26867589
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The rates of oropharyngeal cancers such as tonsil cancers are increasing. The tumour suppressor protein Programmed Cell Death Protein 4 (PDCD4) has been implicated in the development of various human cancers and small RNAs such as microRNAs (miRNAs) can regulate its expression. However the exact regulation of PDCD4 by multiple miRNAs in oropharyngeal squamous cell carcinoma (SCC) is not well understood.

Results: Using two independent oropharyngeal SCC cohorts with a focus on the tonsillar region, we identified a miRNA profile differentiating SCC tissue from normal. Both miR-21 and miR-499 were highly expressed in tonsil SCC tissues displaying a loss of PDCD4. Interestingly, expression of the miRNA machinery, Dicer1, Drosha, DDX5 (Dead Box Helicase 5) and DGCR8 (DiGeorge Syndrome Critical Region Gene 8) were all elevated by greater than 2 fold in the tonsil SCC tissue. The 3'UTR of PDCD4 contains three binding-sites for miR-499 and one for miR-21. Using a wild-type and truncated 3'UTR of PDCD4, we demonstrated that the initial suppression of PDCD4 was mediated by miR-21 whilst sustained suppression was mediated by miR-499. Moreover the single miR-21 site was able to elicit the same magnitude of suppression as the three miR-499 sites.

Conclusion: This study describes the regulation of PDCD4 specifically in tonsil SCC by miR-499 and miR-21 and has documented the loss of PDCD4 in tonsil SCCs. These findings highlight the complex interplay between miRNAs and tumour suppressor gene regulation and suggest that PDCD4 loss may be an important step in tonsillar carcinogenesis.

Citing Articles

Extracellular Vesicle microRNAs as Possible Liquid Biopsy Markers in HNSCC-A Longitudinal, Monocentric Study.

Apeltrath C, Simon F, Riders A, Rudack C, Oberste M Cancers (Basel). 2024; 16(22).

PMID: 39594750 PMC: 11593292. DOI: 10.3390/cancers16223793.


The mechanisms of action of metformin on head and neck cancer in the pre-clinical setting: a scoping review.

Huang L, Woods C, Dharmawardana N, Michael M, Ooi E Front Oncol. 2024; 14:1358854.

PMID: 38454932 PMC: 10917904. DOI: 10.3389/fonc.2024.1358854.


Dysregulated microRNA Expression Relevant to Promoter Mutations in Tonsil Cancer-A Pilot Study.

Kwon M, Park H, Lee J, Kim E, Kim N, Nam E Life (Basel). 2023; 13(10).

PMID: 37895471 PMC: 10608590. DOI: 10.3390/life13102090.


Pathogenesis and prognosis of primary oral squamous cell carcinoma based on microRNAs target genes: a systems biology approach.

Taherkhani A, Dehto S, Jamshidi S, Shojaei S Genomics Inform. 2022; 20(3):e27.

PMID: 36239104 PMC: 9576470. DOI: 10.5808/gi.22038.


BPA Decreases PDCD4 in Bovine Granulosa Cells Independently of miR-21 Inhibition.

Sabry R, Williams M, Werry N, LaMarre J, Favetta L Int J Mol Sci. 2022; 23(15).

PMID: 35955412 PMC: 9368835. DOI: 10.3390/ijms23158276.


References
1.
Thomson J, Parker J, Perou C, Hammond S . A custom microarray platform for analysis of microRNA gene expression. Nat Methods. 2005; 1(1):47-53. DOI: 10.1038/nmeth704. View

2.
Carinci F, Lo Muzio L, Piattelli A, Rubini C, Chiesa F, Ionna F . Potential markers of tongue tumor progression selected by cDNA microarray. Int J Immunopathol Pharmacol. 2005; 18(3):513-24. DOI: 10.1177/039463200501800311. View

3.
Humphreys D, Westman B, Martin D, Preiss T . MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function. Proc Natl Acad Sci U S A. 2005; 102(47):16961-6. PMC: 1287990. DOI: 10.1073/pnas.0506482102. View

4.
Volinia S, Calin G, Liu C, Ambs S, Cimmino A, Petrocca F . A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A. 2006; 103(7):2257-61. PMC: 1413718. DOI: 10.1073/pnas.0510565103. View

5.
Chiosea S, Jelezcova E, Chandran U, Acquafondata M, McHale T, Sobol R . Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol. 2006; 169(5):1812-20. PMC: 1780192. DOI: 10.2353/ajpath.2006.060480. View